Go SearchAdvanced Search

If you have a medical emergency, you should immediately call your emergency telephone hotline (usually 911). If you are seeking medical advice, you should direct those questions to your healthcare provider. Your own healthcare provider is the best source of information regarding your health.

For answers to questions about BYETTA, please refer to the list of Frequently Asked Questions (FAQs). In the FAQ section you will find information about using the BYETTA Pen, pen needles, side effects, and much more.

If you don't find the answers you need, please contact the Amylin Lilly Customer Support Center toll-free at 1-800-868-1190. By calling this telephone number, you will have access to a healthcare provider who can provide additional information similar to what you can find on this website. This toll-free number is not intended to replace the advice of your healthcare provider.

If you need additional information, please contact Amylin or Lilly at the links below.

Amylin Pharmaceuticals, Inc.
http://www.amylin.com/about/contact-us.php

Eli Lilly and Company
http://www.lilly.com/contact/

Go to byetta_insurance_coverage.aspx

Indication

BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program.

BYETTA is not insulin and should not be taken instead of insulin. BYETTA is not recommended to be taken with insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis.

Important Safety Information for BYETTA® (exenatide) injection

  • Serious side effects can happen in people who take BYETTA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder (gallstones), a history of alcoholism, or high blood triglyceride levels. Call your healthcare provider right away if you have pain in your stomach area (abdomen) that is severe, and will not go away. The pain may happen with or without vomiting and may be felt going from your abdomen through to your back.
  • Your risk for getting low blood sugar is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea. The dose of your sulfonylurea medicine may need to be lowered while you use BYETTA.
  • BYETTA should not be used in people who have severe kidney problems and should be used with caution in people who have had a kidney transplant. BYETTA may cause new or worse problems with kidney function, including kidney failure.
  • Before you use BYETTA, tell your healthcare provider if you have severe problems with your stomach, such as delayed emptying of your stomach (gastroparesis) or problems with digesting food.
  • Do not use BYETTA if you have had an allergic reaction to exenatide or any of the other ingredients in BYETTA. Severe allergic reactions can happen with BYETTA. Stop taking BYETTA and get medical help right away.
  • Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if BYETTA will harm your unborn baby. Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.
  • The most common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea most commonly happens when first starting BYETTA, but may become less over time.

These are not all the side effects with BYETTA. Talk to your healthcare provider about any side effect that bothers you or that does not go away.

Please see the BYETTA Prescribing Information and Medication Guide.

Privacy Statement | Terms of Use | Copyright

02-05-1136-B; EX-35924 ©2010 Amylin Pharmaceuticals, Inc. and Lilly USA, LLC.
The BYETTA mark and BYETTA design mark are registered trademarks of Amylin Pharmaceuticals, Inc.
The BYETTA By Your Side mark and design mark are service marks of Amylin Pharmaceuticals, Inc.
All other trademarks are property of their respective owners.
Patent Nos. 5,424,286, 6,858,576, 6,872,700, 6,902,744, 6,956,026, 7,297,761, 7,521,423.
This site is intended for U.S. residents age 18 and over.